FLT3 and acute myeloid leukemia: NGS has been shown to be able to resolve clonal heterogeneity and sequence variability in the assessment of FLT3-ITD-mutated AML [85,86,87,88]; however, the ELN recommends using capillary electrophoresis for better determination of longer ITDs [75].